An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

December 30, 2018

Study Completion Date

December 30, 2018

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Apatinib Mesylate tablet combined with S-1 capsules

Oral use with low-dose Apatinib combined with S-1 until disease progression

Trial Locations (1)

Changzhou Cancer Hospital of Soochow University, Changzhou

All Listed Sponsors

lead

Changzhou Cancer Hospital of Soochow University

OTHER

NCT03129256 - An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter